Is Cullinan Therapeutics, Inc. (CGEM) a Buy, Sell, or Hold?
NASDAQ : CGEM
Cullinan Therapeutics, Inc. — Insider Trades
$19.46 USD
$1.18 (6.46%)
- Volume
- 346.72K
- Average Volume
- 933.5K
- Market Capitalization
- $1.2B
- P/E Ratio
- -5.77
- Dividend Yield
- 0.00%
- Price Target
- $33.50
- Year High
- $19.55
- Year Low
- $5.68
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $8.42
Insider Activity Summary (Last 12 Months)
Insiders Buying
29
Insiders Selling
30
Amount of Insider Selling
$147.91K
CGEM Insider Buying/Selling by Quarter
CGEM Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Michaelson Jennifer | officer: Chief Scientific Officer | 2026-07-06 | M-Exempt | 4.3 | 2026-07-07 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2026-07-06 | S-Sale | 17.82 | 2026-07-07 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2026-07-06 | M-Exempt | 4.3 | 2026-07-07 |
| SUMER JACQUELYN L | officer: Chief Legal Officer | 2026-06-30 | A-Award | 8.6 | 2026-07-02 |
| Fenton Mary Kay | officer: Chief Financial Officer | 2026-06-30 | A-Award | 8.6 | 2026-07-02 |
| Rosenberg Anthony | director | 2026-06-16 | A-Award | 13.55 | 2026-06-18 |
| Meek David D. | director | 2026-06-16 | A-Award | 13.55 | 2026-06-18 |
| Webster Stephen W | director | 2026-06-16 | A-Award | 13.55 | 2026-06-18 |
| Allen Andrew R | director | 2026-06-16 | A-Award | 13.55 | 2026-06-18 |
| Thistle Mary | director | 2026-06-16 | A-Award | 13.55 | 2026-06-18 |
| Doyle Mittie | director | 2026-06-16 | A-Award | 13.55 | 2026-06-18 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2026-05-05 | M-Exempt | 4.3 | 2026-05-06 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2026-05-05 | S-Sale | 14.6 | 2026-05-06 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2026-05-05 | S-Sale | 15.58 | 2026-05-06 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2026-05-05 | M-Exempt | 4.3 | 2026-05-06 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2026-03-05 | M-Exempt | 4.3 | 2026-03-09 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2026-03-05 | S-Sale | 15.68 | 2026-03-09 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2026-03-05 | M-Exempt | 4.3 | 2026-03-09 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2026-02-25 | S-Sale | 14.14 | 2026-02-26 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2026-02-23 | S-Sale | 13.99 | 2026-02-25 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2026-02-24 | S-Sale | 14.47 | 2026-02-25 |
| AHMED NADIM | director, officer: President and CEO | 2026-02-24 | S-Sale | 14.47 | 2026-02-25 |
| Jones Jeffrey Alan | officer: Chief Medical Officer | 2026-02-24 | S-Sale | 14.47 | 2026-02-25 |
| SUMER JACQUELYN L | officer: Chief Legal Officer | 2026-02-24 | S-Sale | 14.47 | 2026-02-25 |
| Jones Jeffrey Alan | officer: Chief Medical Officer | 2026-02-20 | S-Sale | 13.62 | 2026-02-23 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2026-02-20 | M-Exempt | 4.3 | 2026-02-23 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2026-02-20 | S-Sale | 14.3 | 2026-02-23 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2026-02-20 | S-Sale | 13.62 | 2026-02-23 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2026-02-20 | M-Exempt | 4.3 | 2026-02-23 |
| SUMER JACQUELYN L | officer: Chief Legal Officer | 2026-02-20 | S-Sale | 13.62 | 2026-02-23 |
| AHMED NADIM | director, officer: President and CEO | 2026-02-20 | S-Sale | 13.62 | 2026-02-23 |
| Fenton Mary Kay | officer: Chief Financial Officer | 2026-02-20 | S-Sale | 13.62 | 2026-02-23 |
| SUMER JACQUELYN L | officer: Chief Legal Officer | 2026-02-18 | A-Award | 12.44 | 2026-02-19 |
| Jones Jeffrey Alan | officer: Chief Medical Officer | 2026-02-18 | A-Award | 12.44 | 2026-02-19 |
| AHMED NADIM | director, officer: President and CEO | 2026-02-18 | A-Award | 12.44 | 2026-02-19 |
| Savill Corrine | officer: Chief Business Officer | 2026-02-18 | A-Award | 12.44 | 2026-02-19 |
| Fenton Mary Kay | officer: Chief Financial Officer | 2026-02-18 | A-Award | 12.44 | 2026-02-19 |
| Fenton Mary Kay | officer: Chief Financial Officer | 2026-02-18 | A-Award | 0 | 2026-02-19 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2026-02-18 | A-Award | 0 | 2026-02-19 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2026-02-18 | A-Award | 12.44 | 2026-02-19 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2026-02-12 | S-Sale | 12.03 | 2026-02-13 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2026-01-22 | S-Sale | 12.3 | 2026-01-23 |
| Fenton Mary Kay | officer: Chief Financial Officer | 2025-12-31 | A-Award | 6.49 | 2026-01-05 |
| AHMED NADIM | director, officer: President and CEO | 2025-12-23 | S-Sale | 10.01 | 2025-12-29 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2025-12-19 | S-Sale | 10.01 | 2025-12-22 |
| SUMER JACQUELYN L | officer: Chief Legal Officer | 2025-12-18 | S-Sale | 9.67 | 2025-12-19 |
| Jones Jeffrey Alan | officer: Chief Medical Officer | 2025-12-18 | S-Sale | 9.67 | 2025-12-19 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2025-12-18 | S-Sale | 9.67 | 2025-12-19 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2025-12-12 | S-Sale | 12.38 | 2025-12-16 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2025-12-15 | S-Sale | 11.9 | 2025-12-16 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2025-11-24 | S-Sale | 12.3 | 2025-11-25 |
| Lynx1 Capital Management LP | 10 percent owner | 2025-10-28 | P-Purchase | 8.4005 | 2025-10-30 |
| Lynx1 Capital Management LP | 10 percent owner | 2025-10-17 | P-Purchase | 7.8395 | 2025-10-21 |
| Lynx1 Capital Management LP | 10 percent owner | 2025-10-16 | P-Purchase | 8.855 | 2025-10-21 |
| Lynx1 Capital Management LP | 10 percent owner | 2025-10-15 | P-Purchase | 7.9427 | 2025-10-21 |
| Lynx1 Capital Management LP | 10 percent owner | 2025-10-14 | P-Purchase | 7.587 | 2025-10-21 |
| Lynx1 Capital Management LP | 10 percent owner | 2025-10-10 | P-Purchase | 7.3617 | 2025-10-10 |
| Lynx1 Capital Management LP | 10 percent owner | 2025-10-09 | P-Purchase | 6.6958 | 2025-10-10 |
| Lynx1 Capital Management LP | 10 percent owner | 2025-10-08 | P-Purchase | 6.46 | 2025-10-10 |
| Lynx1 Capital Management LP | 10 percent owner | 2025-10-08 | 0 | 2025-10-10 | |
| Doyle Mittie | director | 2025-08-07 | A-Award | 7.03 | 2025-08-08 |
| Allen Andrew R | director | 2025-08-07 | A-Award | 7.03 | 2025-08-08 |
| Allen Andrew R | 2025-08-07 | 0 | 2025-08-08 | ||
| Doyle Mittie | 2025-08-07 | 0 | 2025-08-08 | ||
| Ryan David P. | director | 2025-06-12 | A-Award | 8.95 | 2025-06-16 |
| Rosenberg Anthony | director | 2025-06-12 | A-Award | 8.95 | 2025-06-16 |
| Webster Stephen W | director | 2025-06-12 | A-Award | 8.95 | 2025-06-16 |
| Meek David D. | director | 2025-06-12 | A-Award | 8.95 | 2025-06-16 |
| Martin Anne-Marie | director | 2025-06-12 | A-Award | 8.95 | 2025-06-16 |
| Jones Jeffrey Alan | officer: Chief Medical Officer | 2025-02-25 | S-Sale | 8.53 | 2025-02-27 |
| AHMED NADIM | director, officer: President and CEO | 2025-02-25 | S-Sale | 8.53 | 2025-02-27 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2025-02-25 | S-Sale | 8.53 | 2025-02-27 |
| SUMER JACQUELYN L | officer: Chief Legal Officer | 2025-02-25 | S-Sale | 8.53 | 2025-02-27 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2025-02-19 | A-Award | 0 | 2025-02-21 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2025-02-19 | A-Award | 9.43 | 2025-02-21 |
| Savill Corrine | officer: Chief Business Officer | 2025-02-19 | A-Award | 0 | 2025-02-21 |
| Savill Corrine | officer: Chief Business Officer | 2025-02-19 | A-Award | 9.43 | 2025-02-21 |
| SUMER JACQUELYN L | officer: Chief Legal Officer | 2025-02-19 | A-Award | 0 | 2025-02-21 |
| SUMER JACQUELYN L | officer: Chief Legal Officer | 2025-02-19 | A-Award | 9.43 | 2025-02-21 |
| AHMED NADIM | director, officer: President and CEO | 2025-02-19 | A-Award | 0 | 2025-02-21 |
| AHMED NADIM | director, officer: President and CEO | 2025-02-19 | A-Award | 9.43 | 2025-02-21 |
| Jones Jeffrey Alan | officer: Chief Medical Officer | 2025-02-19 | A-Award | 0 | 2025-02-21 |
| Jones Jeffrey Alan | officer: Chief Medical Officer | 2025-02-19 | A-Award | 9.43 | 2025-02-21 |
| Fenton Mary Kay | officer: Chief Financial Officer | 2025-02-19 | A-Award | 9.43 | 2025-02-21 |
| Fenton Mary Kay | officer: Chief Financial Officer | 2025-02-19 | A-Award | 0 | 2025-02-21 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2025-01-06 | S-Sale | 12.51 | 2025-01-07 |
| AHMED NADIM | director, officer: President and CEO | 2024-12-24 | S-Sale | 11.87 | 2024-12-27 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2024-12-18 | S-Sale | 11.41 | 2024-12-20 |
| Jones Jeffrey Alan | officer: Chief Medical Officer | 2024-12-18 | S-Sale | 11.41 | 2024-12-20 |
| SUMER JACQUELYN L | officer: Chief Legal Officer | 2024-12-18 | S-Sale | 11.41 | 2024-12-20 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2024-12-12 | S-Sale | 12.52 | 2024-12-16 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2024-11-05 | S-Sale | 15.64 | 2024-11-07 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2024-09-05 | S-Sale | 18.09 | 2024-09-09 |
| Thistle Mary | 2024-08-08 | 0 | 2024-08-09 | ||
| Thistle Mary | director | 2024-08-08 | A-Award | 16.38 | 2024-08-09 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2024-07-05 | S-Sale | 16.33 | 2024-07-09 |
| Michaelson Jennifer | officer: Chief Scientific Officer | 2024-07-01 | A-Award | 9 | 2024-07-02 |
| Webster Stephen W | director | 2024-06-26 | A-Award | 16.5 | 2024-06-27 |
| Rosenberg Anthony | director | 2024-06-26 | A-Award | 16.5 | 2024-06-27 |
| Martin Anne-Marie | director | 2024-06-26 | A-Award | 16.5 | 2024-06-27 |